Posted in | News | Nanomaterials | Nanobusiness

Calls for More Resaerch into Potential Risks of Nanotechnology

The Council for Science and Technology—the British government’s top-level advisory body on science and technology issues—criticized the slow progress being made in providing needed support for focused research into the potential hazards of nanotechnology. CST’s comments are contained in a new review of the UK government’s response to recommendations made by the Royal Society and Royal Academy of Engineering in their landmark 2004 assessment of nanotechnology’s opportunities and hazards.

“The UK government deserves a lot of credit for commissioning both the ground-breaking 2004 Royal Society report and for submitting itself to a tough review of its performance since then,” said Project on Emerging Nanotechnologies chief scientist Andrew Maynard.

The new high-level review concluded that not enough is being done to address uncertainties over the environmental, health, and safety impacts of nanomaterials. The CST found funding support and effective research strategies to be lacking.

“The UK is not alone in falling short on funding for research to address the uncertainties surrounding the environmental, health and safety risks of engineered nanoscale materials” said Maynard. “Altogether, governments in the United States and other nations spend about $5 billion globally each year on nanotechnology research and development. If held up to the same scrutiny, their risk research plans and funding levels would earn equally disappointing marks.”

“The specific health and safety questions that are important to be addressed for nanotechnology are reasonably straightforward,” noted Maynard. “And a lot already has been published about what we know and do not know about the potential risks and about how to fill existing research gaps. Far harder is getting governments to set risk research priorities and to develop and sufficiently fund an internationally-coordinated risk research plan for nanotechnology.”

Maynard proposes that the U.S. federal government invest a minimum of $100 million over the next two years in targeted risk research in order to lay a strong, science-based foundation for safe nanotechnology. According to Maynard’s analysis, despite investing more than $1 billion annually on nanotechnology research, U.S. government spending on highly relevant nanotech risk research was only $11 million in 2005.

“With an estimated $2.6 trillion in manufactured goods expected to incorporate nanotechnology globally by 2014, there’s a lot at stake in ‘getting it right’ and in addressing nanotechnology environment and safety questions early,” stressed Maynard. “As both the Republican and Democratic leaders of the U.S. House of Representatives Committee on Science declared last year, ‘Nanotechnology is an area of research that could add billions of dollars to our economy, but that won’t happen if it is shrouded in uncertainty about its consequences.’ ”

“The American government needs to take action urgently in three critical areas of nanotechnology: first, documenting what relevant risk research exists; second, ensuring that agencies responsible for oversight and related research—the Environmental Protection Agency (EPA), Food & Drug Administration (FDA), National Institute of Environmental Health Sciences (NIEHS), National Institute for Occupational Safety & Health (NIOSH), the Consumer Product Safety Commission (CPSC)—are adequately funded; and third, developing a robust, top-down research plan that can be implemented by the U.S. government and used for collaborations with industry and with researchers in other countries,” said Maynard.

“Nanotechnology is no longer a scientific curiosity,” he added. “Nanomaterials and nanoproducts are in the workplace, the environment, and the home. But if people are to realize nanotechnology’s benefits—in medicine, electronics, and sustainable energy production—governments around the world need a master plan for identifying and reducing potential risks. This plan should include a top-down risk research strategy, sufficient funding to do the job, and the mechanisms to ensure that resources are used effectively.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.